Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1622 1671 1692
This examiner grants 86% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18264160 | ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES | Non-Final OA | DSM IP ASSETS B.V. |
| 17919939 | PROCESS FOR THE PREPARATION OF ALPHA,OMEGA-ALKANEDIOL MONONITRATE | Final Rejection | DSM IP ASSETS B.V. |
| 17794322 | COMPOSITION AND METHOD FOR PRODUCING SAME | Non-Final OA | DAICEL CORPORATION |
| 18279862 | PRODUCTION EQUIPMENT AND PRODUCTION METHOD FOR CUMENE HYDROPEROXIDE | Non-Final OA | Sumitomo Chemical Company, Limited |
| 18276341 | PROCESS AND PLANT FOR PRODUCING E-FUELS | Non-Final OA | TOPSOE A/S |
| 18550801 | PROCESS FOR THE PURIFICATION OF VANILLIN OR A VANILLIN DERIVATIVE OBTAINED BY A BIOTECHNOLOGICAL PROCESS | Non-Final OA | SPECIALTY OPERATIONS FRANCE |
| 18550941 | PROCESS FOR THE PURIFICATION OF VANILLIN OR A VANILLIN DERIVATIVE OBTAINED BY A BIOTECHNOLOGICAL PROCESS | Non-Final OA | SPECIALTY OPERATIONS FRANCE |
| 18277158 | METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND | Non-Final OA | API CORPORATION |
| 18210862 | TRANS-CYCLOOCTENES WITH HIGH REACTIVITY AND FAVORABLE PHYSIOCHEMICAL PROPERTIES | Non-Final OA | UNIVERSITY OF DELAWARE |
| 18198809 | Branched Aldehyde Production | Non-Final OA | SCION Holdings LLC |
| 17928368 | Branched Alcohols | Non-Final OA | SCION Holdings LLC |
| 18251256 | HYDROFORMYLATION REACTION PROCESSES | Non-Final OA | Dow Technology Investments LLC |
| 18108509 | VITAMIN C PREPARATION | Non-Final OA | ONE INNOVATION LABS, LLC |
| 18079344 | VITAMIN C PREPARATION | Non-Final OA | ONE INNOVATION LABS, LLC |
| 18154917 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | Non-Final OA | Heron Neutron Medical Corp. |
| 18002673 | USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR TRANSPORTING VEHICLE | Final Rejection | I.COM MEDICAL GMBH |
| 17907414 | USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING IMMUNOMODULATORY EFFECTS IN CANCER TREATMENT | Non-Final OA | Faculdade de Medicina da Universidade de Lisboa |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy